Singular Genomics Systems Inc Revenue Growth Rates (OMIC), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Singular Genomics Systems Inc   (NASDAQ: OMIC)
 

OMIC's Revenue Growth by Quarter and Year

Singular Genomics Systems Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OMIC Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December -
3rd Quarter September 0.41
2nd Quarter June 0.74
1st Quarter March 0.44
FY 1.59





OMIC Revenue third quarter 2024 Y/Y Growth Comment
Singular Genomics Systems Inc reported fall in Revenue in the third quarter 2024 by -11.74% to $ 0.41 millions, from the same quarter in 2023.
The decline in the third quarter 2024 Singular Genomics Systems Inc 's Revenue compares unfavorably to the Company's average Revenue growth of 6.59%.

Looking into third quarter 2024 results within Laboratory Analytical Instruments industry 17 other companies have achieved higher Revenue growth. While Singular Genomics Systems Inc ' s Revenue decrease of -11.74% ranks overall at the positon no. 3072 in the third quarter 2024.


OMIC Revenue ( Y/Y Growth %) 2024
 2023 2022 2021
4th Quarter December - 40.26 % - -
3rd Quarter September -11.74 % - - -
2nd Quarter June 45.1 % - - -
1st Quarter March -48.84 % - - -
FY   - 277.92 % - -

Financial Statements
Singular Genomics Systems Inc 's third quarter 2024 Revenue $ 0.41 millions OMIC's Income Statement
Singular Genomics Systems Inc 's third quarter 2023 Revenue $ 0.46 millions Quarterly OMIC's Income Statement


OMIC Revenue (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
4th Quarter December - 134.78 % - -
3rd Quarter September -45.14 % -9.8 % - -
2nd Quarter June 68.18 % -40.7 % - -
1st Quarter March -59.26 % 11.69 % - -
FY (Year on Year)   - 277.92 % - -


Back to OMIC Growth rate Comparisons >> Back to OMIC Growth rate Comparisons >>


Revenue third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #18
Healthcare Sector #458
Overall #3072

Revenue Y/Y Growth Statistics
High Average Low
45.94 % 6.59 % -48.78 %
(Sep 30 2024)  
Revenue third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #18
Healthcare Sector #458
Overall #3072
Revenue Y/Y Growth Statistics
High Average Low
45.94 % 6.59 % -48.78 %
(Sep 30 2024)  

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Singular Genomics Systems Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
133.98 % 8.5 % -59.11 %
(Dec 31 2023)  


OMIC's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2024 Singular Genomics Systems Inc disclosed fall in Revenue from the second quarter by -45.14% to $ 0.41 millions, from $ 0.74 millions achived in the previous reporting period.

But that's not important problem, as Singular Genomics Systems Inc 's Revenue generally seem to plunge in this quarter.

Within Laboratory Analytical Instruments industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Singular Genomics Systems Inc 's Revenue growth quarter on quarter, overall rank is 3784.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #23
Healthcare Sector #581
Overall #3784
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #23
Healthcare Sector #581
Overall #3784
Revenue Q/Q Growth Statistics
High Average Low
133.98 % 8.5 % -59.11 %
(Dec 31 2023)  


OMIC's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2024 Singular Genomics Systems Inc disclosed fall in Revenue from the second quarter by -45.14% to $ 0.41 millions, from $ 0.74 millions achived in the previous reporting period.

But that's not important problem, as Singular Genomics Systems Inc 's Revenue generally seem to plunge in this quarter.

Within Laboratory Analytical Instruments industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Singular Genomics Systems Inc 's Revenue growth quarter on quarter, overall rank is 3784.


Singular Genomics Systems Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Sep 30 2023)
Cumulative Revenue 12 Months Ending $ 2.67 $ 2.72 $ 2.49 $ 2.91 $ 2.60
Y / Y Revenue Growth (TTM) 2.74 % - - - -
Year on Year Revenue Growth Overall Ranking # 1655 # 0 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) -2.06 % 9.32 % -14.46 % 12.18 % -
Seq. Revenue Growth (TTM) Overall Ranking # 906 # 944 # 0 # 0 # 0


Cumulative Revenue growth Comment
With 2.74% annual Revenue growth, Singular Genomics Systems Inc would report a record annual Revenue improvement if the fiscal year would end on Sep 30 2024.

In the Healthcare sector 299 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 1655.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 6
Healthcare Sector # 300
Overall # 1655

Revenue TTM Y/Y Growth Statistics
High Average Low
2.74 %
 2.74 %
2.74 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 214
S&P 500 # 906
Cumulative Revenue growth Comment
With 2.74% annual Revenue growth, Singular Genomics Systems Inc would report a record annual Revenue improvement if the fiscal year would end on Sep 30 2024.

In the Healthcare sector 299 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 1655.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 6
Healthcare Sector # 300
Overall # 1655

Revenue TTM Y/Y Growth Statistics
High Average Low
2.74 %
2.74 %
2.74 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 214
S&P 500 # 906




Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
OMIC's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue improvement for the quarter ending Sep 30 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2024
West Pharmaceutical Services Inc -0.08%$ -0.080 millions
Nektar Therapeutics-0.08%$ -0.083 millions
Apyx Medical Corp-0.22%$ -0.219 millions
Avantor Inc -0.34%$ -0.337 millions
Avanos Medical Inc -0.35%$ -0.352 millions
Integra Lifesciences Holdings Corp-0.41%$ -0.415 millions
Nuwellis Inc -0.59%$ -0.588 millions
Alkermes Plc -0.73%$ -0.734 millions
Prestige Consumer Healthcare Inc -0.92%$ -0.922 millions
Psychemedics Corporation-1.02%$ -1.021 millions
Petros Pharmaceuticals inc -1.34%$ -1.342 millions
10x Genomics Inc -1.39%$ -1.391 millions
Abcellera Biologics Inc -1.39%$ -1.394 millions
Nephros Inc -1.41%$ -1.409 millions
Charles River Laboratories International inc -1.64%$ -1.642 millions
Inspiremd Inc -1.67%$ -1.669 millions
Cv Sciences Inc -1.69%$ -1.691 millions
Elutia Inc -1.71%$ -1.712 millions
Enhabit Inc -1.82%$ -1.820 millions
Accuray Incorporated-1.96%$ -1.956 millions
Zimvie Inc -1.98%$ -1.984 millions
Reflect Scientific Inc-2.25%$ -2.254 millions
Upstream Bio Inc -2.25%$ -2.254 millions
Maravai Lifesciences Holdings Inc -2.49%$ -2.490 millions
Biogen Inc -2.55%$ -2.549 millions
Fresenius Medical Care Ag-2.66%$ -2.658 millions
Opko Health Inc -2.78%$ -2.779 millions
Precision Optics Corporation Inc -2.87%$ -2.874 millions
Msa Safety Inc-2.98%$ -2.985 millions
Teladoc Health Inc -2.99%$ -2.988 millions


About Singular Genomics Systems Inc Revenue Growth Rates (OMIC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Singular Genomics Systems Inc (CIK 1850906).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0000950170-24-125405
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Singular Genomics Systems Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.